Celgene and Juno Announce Celgene Exercised Option to Develop and Commercialize CD19-directed Product Candidates
EraNova Announces Positive Preliminary Economic Assessment for the Adanac Molybdenum Project: After-Tax NPV of $714.4 Million and 23.5% IRR
